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Expression of human heme oxygenase-1 in the thick ascending
limb attenuates angiotensin II–mediated increase
in oxidative injury1
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Expression of human heme oxygenase-1 in the thick ascending
limb attenuates angiotensin II–mediated increase in oxidative
injury.
Background. Heme oxygenase-1 (HO-1) catalyzes the con-
version of heme to bilirubin, carbon monoxide (CO), and free
iron, thus controlling the level of cellular heme. The medullary
thick ascending limb of the loop of Henle (TALH) is situated
in a site of markedly diminished oxygen tension and, as such, is
highly vulnerable to ischemic insult. We hypothesize that selec-
tive upregulation of HO-1 in TALH by gene transfer attenuates
oxidative stress caused by angiotensin II (Ang II).
Methods. An adenoviral vector expressing the human HO-1
under the control of the TALH-specific promoter [Na+-K+-Cl−
cotransporter (NKCC2 promoter)] was constructed and the cell
specific expression of the recombinant adenovirus was exam-
ined using several types of cells, including endothelial, vascular
smooth muscle, and TALH cells. The effects of HO-1 transduc-
tion on HO-1 expression, HO activity and the response to Ang
II with respect to cyclooxygenase-2 (COX-2) up-regulation and
oxidative injury [growth-stimulating hormone (GSH) levels and
cell death] were determined.
Results. Western blot and reverse transcription-polymerase
chain reaction (RT-PCR) revealed that human HO-1 was se-
lectively expressed in primary cultured TALH cells follow-
ing infection with Ad-NKCC2-HO-1. In TALH cells infected
with Ad-NKCC2-HO-1, Ang II-stimulated prostaglandin E2
(PGE2) levels were reduced by 40%. Ang II caused a marked
decrease in GSH levels and this decrease was greatly attenuated
in TALH cells transduced with Ad-NKCC2-HO-1. Moreover,
Ang II–mediated DNA degradation was completely blocked by
the site-specific expression of human HO-1 gene.
Conclusion. These results indicate that TALH cell survival
after exposure to oxidative stress injury may be facilitated by
1See Editorial by Chang and Perrella, p. 1968
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selective upregulation of HO-1, thusly blocking inflammation
and apoptosis.
The thick ascending loop of Henle (TALH) segment
of the nephron, residing in the oxygen-poor medulla of
the kidney, is highly susceptible to oxidants, and tubular
hypoxic and oxidative injury [1]. Extensive DNA frag-
mentation has been observed selectively in TALH cells
soon after local hypoxia [2]. Increased superoxide lev-
els in TALH have been shown to decrease nitric oxide
bioavalibilty and stimulate NaCl absorption [3]. An-
giotensin II (Ang II) is a pro-oxidant agent, which induces
renal oxidative stress and predisposes to acute renal fail-
ure [4]. Ang II up-regulates heme oxygenase-1 (HO-1)
[5], a stress-responsive protein, as an adaptive response
to injury [6].
HO is present in the kidney as the constitutive isoform,
HO-2, and as the inducible isoform, HO-1. Induction of
HO-1 has been shown to attenuate tumor necrosis factor-
a (TNF-a)–mediated cell death by retroviral delivery of
human HO-1 gene into human microvessel endothelial
cells [7, 8]. Cyclooxygenase 2 (COX-2) activity was de-
creased, as was p27, a cyclin-dependent kinase inhibitor.
HO-1 gene up-regulation has been shown to attenuate
Ang II–mediated DNA damage in endothelial cells [9].
HO-1 regulates the rate of heme degradation, leading to
equimolar amounts of carbon monoxide (CO), iron and
biliverdin metabolized to bilirubin, which is a potent an-
tioxidant [10, 11]. CO, in addition to activating the cyclic
guanosine monophosphate (cGMP) pathway and elicit-
ing vasodilation [12], has also been shown to function
as an anti-inflammatory and cytoprotective molecule [7,
8, 13–16]. CO has also been shown to participate in the
regulation of ion channels, including the apical 70-pS K-
channel activity of the TALH [17].
In view of the importance of HO-1 in preventing the
consequences of oxidative stress, we studied the effect
of augmenting HO-1 activity by transducing TALH cells
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with human HO-1 gene and determining if this could pro-
tect TALH against the toxic effects of free heme and the
Ang II–mediated increase in oxidative stress. We utilized
an adenoviral vector for human HO-1 with the TALH-
specific promoter, NKCC2. NKCC2 encoded by a distinct
gene is selectively expressed in the TALH and represents
the apical Na+-K+-Cl− cotransporter that mediates ac-
tive reabsorption of NaCl [18]. Recent studies by Ortiz
et al [19, 20] have shown elegantly the specificity of the
NKCC2 promoter in directing TALH-specific expression
of the marker gene green fluorescent protein (GFP) as
well as endothelial nitric oxide synthase (eNOS) [19, 20].
These authors demonstrated that administration of ade-
noviruses expressing either GFP or eNOS under the con-
trol of the NKCC2 promoter resulted in their exclusive
expression in TALH but not in other structures of the
transduced kidney.
In this study, we demonstrated that it is possible to
transduce, in a site-specific fashion, TALH cells with
the human HO-1 gene and achieve selective overexpres-
sion of human HO-1 protein to levels significantly higher
than those of endogenous rat HO-1 protein. Overexpres-
sion of human HO-1 was not associated with changes
in endogenous HO-2 expression. We have also shown
that augmentation of human HO-1 activity in transduced
TALH cells confers substantial protection against Ang
II–induced oxidative injury, and demonstrated a link be-
tween up-regulation of HO-1 and TALH survival. Over-
expression of HO-1, via HO-1 gene transfer, prevented
Ang II–stimulated DNA degradation and up-regulated
growth-stimulating hormone (GSH) levels. These results
may provide the rationale for a possible strategy to pro-
tect TALH from the consequences of tubular hypoxic and
oxidative injury with subsequent oxidative stress-inspired
inflammation and apoptosis.
METHODS
Animals
Male Sprague-Dawley rats, 7 to 8 weeks old (Charles
River Lab, Wilmington, MA, USA), weighing 100 to
115 g, were maintained on standard rat chow (Ralston-
Purina, Chicago, IL, USA) and given tap water ad libitum.
Isolation of TALH cells and cell culture
Rat TALH cells were isolated and characterized using
a standard primary culture procedure as described pre-
viously [21–24]. The cells were cultured in Dulbecco’s
minimum essential medium (DMEM) (Life Technolo-
gies, Grand Island, NY, USA) containing 10% fetal
bovine serum (FBS) and 20 ng/mL epithelial growth
factor (EGF). After 3 to 5 days, monolayers of cells
were 50% to 60% confluent. Rat lung microvessel en-
dothelial cells (EC) were cultured in MCDB131 medium
with 10% FBS, 10 ng/mL EGF, 1 lL/mL hydrocorti-
sone, 0.1 mg/mL ENDO GRO (VEC Technologies, Rens-
selaer, NY, USA), and 90 lg/mL heparin (Sigma, St.
Louis, MO, USA) [25, 26]. Rat aorta smooth muscle cells
(SMC) were purchased from ATCC (American Type Tis-
sue Culture, Manassas, VA, USA) and were grown in
DMEM medium with 10% FBS. HEK-293 cells (ATCC)
were grown in DMEM supplemented with 10% FBS.
All cells were incubated at 37◦C in a 5% CO2 humid-
ified atmosphere, and maintained at subconfluency by
passaging with trypsin-ethylenediaminetetraacetic acid
(EDTA) (Life Technologies). Cells were treated with var-
ious inducers of HO-1, either SnCl2 (10 lmol/L), heme
(10 lmol/L), or Ang II (100 ng/mL), and the levels of
HO-1 and HO-2, as well as prostaglandin E2 (PGE2),
were measured.
Isolation of NKCC2 promoter
Since the NKCC2 transcript is only detected in the
kidney [18, 27] and is restricted to TALH, a 1702 bp
NKCC2 promoter was amplified from mouse genomic
DNA, using the primer sets that overlap the NKCC2 pro-
moter region (−1629 to +48), and cloned into plasmid
pCRII (Invitrogen, Carlsbad, CA, USA) as previously
described [28], the resultant plasmid was designated
as pCRII-NKCC2. The 5′primer and 3′primer were as
follows: 5′-CCCCAACACACAAATCGATAGCTG-3′
and 5′-CCAGACAACTTACCGCCCATCC-3′, respec-
tively. The amplified NKCC2 promoter region was se-
quenced and analyzed by digestion with restriction
endonucleotidase.
Construction of adenovirus expressing
NKCC2-controlled HO-1 gene
The 1702 bp NKCC2 promoter was released from
pCRII-NKCC2 by the digestion with XbaI and KpnI, and
subcloned at the XbaI/KpnI sites of pShuttle (Stratagene,
La Jolla, CA, USA). The resultant plasmid was desig-
nated as pShuttle-NKCC2. The cytomegalovirus (CMV)
promoter was removed from pShuttle-NKCC2 by MfeI
and NheI. The resultant plasmid, after self-ligation of the
end-blunted vector, was named as pSh-NKCC2. The 987
bp human HO-1 (HHO-1) cDNA fragment coding for
the full length of HO-1 protein was released from the
plasmid pGEM-HHO-1 [25, 26] by HindIII. The released
human HO-1 fragment was blunted with desoxynucle-
oside triphosphate (dNTP) and T4 DNA polymerase
and inserted at the end-blunted BamHI site of pSh-
NKCC2. The transcriptional orientated clone was named
pSh-NKCC2-HO-1. The adenoviral vector, Ad-NKCC2-
HO-1, was constructed by subcloning the NKCC2-HO-1
DNA fragment from pSh-NKCC2-HO-1 into I-ceuI/PI-
sceI sites of Adeno-X viral DNA (Stratagene). After
digestion with PacI, Ad-NKCC2-HO-1 was transfected
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Table 1. Synthetic primers for polymerase chain reaction (PCR) or
reverse transcription (RT)-PCR analysis
Amplified DNA
fragments Primer sequences
Adenoviral vector Upstream 5′-GAAGACAATAGCA
(370 bp) GGCATGC-3′
Downstream 5′-GTAGGTCAAGGTAGT
AGAGTTT-3′
NKCC2 promoter Upstream 5′-CCCCAACACAC
(1702 bp) AAATCGAT-3′
Downstream 5′-GCCCAGACACTTACCGC
CCCATC-3′
Human HO-1 cDNA Upstream 5′-CAGGCAGAGAATGC
(550 bp) TGAGTTC-3′
Downstream 5′-GATGTTGAGCAGGA
ACGCAGT-3′
Rat b-actin Upstream 5′-TTGTAACCAACTGGGACG
(764 bp) ATATGG-3′
Downstream 5′-GATCTTGATCTTCATGGT
GCTAGG-3′
HO-1 is heme oxygenase-1.
into HEK-293 cells. Adenoviruses harvested from trans-
fected 293 cells were identified by polymerase chain re-
action (PCR) and viral titer assay, and were used to infect
different kinds of cells. Control adenovirus Ad-lacZ
was obtained from Quantum Biotechnologies (Montreal,
Quebec, Canada), in which the lacZ gene is under the
control of the CMV promoter. The results showed that
the amplified NKCC2 promoter sequence was identical
to that published previously [28].
Reverse transcription (RT)-PCR and PCR analysis
of human HO-1 expression in TALH
RT was carried out using the AdvantageTM RT-for-
PCR Kit (Clontech, Palo Alto, CA, USA). Poly-d(T)n
was used as the RT primer. Specific primers for am-
plifying human HO-1 and the adenoviral vector gene
fragment are listed in Table 1. PCR was performed us-
ing a Taq PCR Kit (Roche, Indianapolis, IN, USA). For
each RT-PCR, a sample without reverse transcriptase was
processed in parallel and served as a negative control.
Cycling parameters for amplifying RT products were as
follows: 95◦C, 1 minute; 60◦C, 1 minute; 72◦C, 1 to 3 min-
utes, for 30 cycles, and then extended at 72◦C for another
5 minutes. After amplification, PCR products were elec-
trophoresed on 1.2% agarose gel, stained with ethidium
bromide, and visualized under ultraviolet light. Genomic
DNA was extracted from cells using the DNeasy Tissue
Kit (Qiagen, Valencia, CA, USA). Different combina-
tions of primers (Table 1) were used to amplify the inte-
grated DNA fragments via the Expand High Fidelity PCR
System (Roche). Cycling parameters were as described
above.
Western blot
Cells were harvested using cell lysis buffer as described
previously [25]. The lysate was collected for Western blot
analysis. Protein levels were visualized by immunoblot-
ting with antibodies against human HO-1 (which does not
crossreact with rat HO-1), rat HO-1 (which crossreacts
with human HO-1) and rat HO-2 (Stressgen, Vancou-
ver, British Columbia, Canada). Briefly, 30 lg of lysate
supernatant was separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred to a nitrocellulose membrane (Amersham,
Inc., Piscataway, NJ, USA) using a semidry transfer ap-
paratus (Bio-Rad, Hercules, CA, USA). The membranes
were incubated with 5% milk in 10 mmol/L Tris-HCl
(pH 7.4), 150 mmol/L NaCl, 0.05% Tween 20 (TBST)
buffer at 4◦C overnight. After washing with TBST, the
membranes were incubated with a 1:2000 dilution of anti-
HO-1 or anti-HO-2 antibodies for 1 hour at room tem-
perature with constant shaking. The filters were washed
and subsequently probed with horseradish peroxidase-
conjugated donkey antirabbit IgG (Amersham) at a
dilution of 1:2000. Chemilluminescence detection was
performed with the Amersham ECL detection kit accord-
ing to the manufacturer’s instructions.
Identification of human and rat HO-1 genes in rat
TALH cells by confocal images
A monoclonal antibody against human HO-1, rat HO-
1 and a polyclonal antibody against HO-2 were purchased
from Stressgen. Cells were plated on Lab-Tek Cham-
ber Slides (Nalge Nunc International, Urbana, IL, USA)
and cultured for 3 to 4 days until they reached 50%
to 60% confluency. After a 2-day infection with aden-
oviruses, the cells were fixed in 4% paraformaldehyde
for 10 minutes at room temperature, permeabilized with
0.1% Triton X-100 and blocked with 10% normal goat
serum followed by incubation with primary antibodies
for 2 hours and secondary antibodies [fluorescein isothio-
cyanate (FITC)-conjugated goat antimouse IgG and Cy3-
conjugated goat antirabbit IgG antibodies] for 1 hour.
After several washes in phosphate-buffered saline (PBS),
the slides were mounted using Slow Fade (Molecular
Probes, Eugene, OR, USA). Immunofluorescence was
visualized by confocal microscopy (Olympus Fluoview
FV300) (Olympus, Melville, NY, USA).
HO activity
HO activity was assayed in cell homogenates by a previ-
ously described method [29]. Briefly, bilirubin, the prod-
uct of HO degradation, was extracted with chloroform
and its concentration was determined spectrophotomet-
rically using the difference in absorbance at wavelength
from k 460 to k 530 nm with an absorption coefficient of
40 mM−1 and cm−1 [29].
Microsomal heme and PGE2 determination
Microsomal heme was determined as the pyridine
hemochromogen by using the reduced minus oxidized
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difference in absorbance at k 400 and k 600 nm with
an absorption coefficient of 32.4 mM−1 cm−1 [25]. For
measurement of PGE2, medullary thick ascending limb
(mTAL) cells were incubated for 24 hours after treat-
ment with different chemicals, after which the cell-free
supernatants were assayed for PGE2 using the enzyme-
linked immunosorbent assy (ELISA) kit according to the
manufacturer’s specifications (Cayman, Ann Arbor, MI,
USA) at 450 nm [26].
DNA analysis by COMET assay
The presence of DNA fragmentation was examined by
single-cell electrophoresis (COMET assay), as previously
described [9]. Briefly, 0.5 to 0.8 × 105 cells were mixed
with 75 lL 0.5% low-melting agarose (LMA) and spotted
on slides. The “minigels” were maintained in lysis solution
[N-laurosil-sarcosine 1%, NaCl 2.5 mol/L, Na2EDTA
100 mmol/L, dimethyl sulfoxide (DMSO) 10%, pH 10] for
1 hour at 4◦C, then denatured in a high pH buffer (NaOH
300 mmol/L and Na2EDTA 1 mmol/L) for 20 minutes
and finally electrophoresed in the same buffer at 25 V
for 50 to 60 minutes. At the end of the run, the minigels
were neutralized in Tris-HCl 0.4 mol/L, pH 7.5, stained
with 100 lL ethidium bromide (2 lg/mL) for 10 minutes,
and scored using a Nikon fluorescence microscope
(Nikon Labophot) interfaced with a computer. The Soft-
ware Scion Image with a COMET 1.3 version macro (free
download from NIH web site) allowed us to analyze and
quantify DNA damage by measuring (1) tail length (TL)
and (2) tail DNA percentage (TDNA). These parameters
are employed by the software to determine the level of
DNA damage as tail moment (TMOM) expressed as the
product of TL and TDNA.
GSH levels
GSH levels were quantitatively measured by spec-
trophotometric method. GSH contents were expressed
in nmol of GSH per mg of protein. Briefly, 300 lL of
lysate was mixed with 10 lL of trichloroacetic acid (30%
wt/vol) in an Eppendorf tube for 15 minutes in ice. The
mixture was centrifuged (3000g for 10 minutes at 4◦C),
and 100 lL of supernatant was mixed with 0.880 mL of
Tris (0.25 mol/L)-EDTA (20 mmol/L) (TE) buffer (pH
8.2) and 20 lL of 10 mmol/L 2,2-dithiobisnitrobenzoic
acid (DTNB). The color was developed for 15 to 20 min-
utes at room temperature. The absorbance of the super-
natant was measured at 412 nm and subtracted from a
DTNB-TE blank.
Statistical analysis
The data are presented as mean ± standard error (SE)
for the number of experiments. Statistical significance
(P < 0.05) between the experimental groups was deter-
mined by the Fisher methods for multiple comparisons.
For comparison between treatment groups, the null hy-
pothesis was tested by single-factor analysis of variance
(ANOVA) for multiple groups or unpaired t test for two
groups.
RESULTS
Effect of Ang II and inducers on HO-1 and HO-2
protein expression
HO-1 protein expression in TALH cells treated with
different HO-1 inducers was analyzed by Western blot.
Primary cultures of mTAL cells expressed significant
basal levels of HO-1 protein. However, HO-1 expression
in mTAL cells in response to inducers (i.e., SnCl2, heme,
and Ang II) was different from the response obtained
in endothelial cells and vascular smooth muscle cells.
As seen in Figure 1, when equal amounts of cell lysates
(30 lg) from three different cell types (TALH, endothe-
lial, and vascular smooth muscle) were loaded for West-
ern blot analyses under the same conditions, basal HO-1
was expressed at relatively higher levels in TALH cells
compared to endothelial and vascular smooth muscle
cells. Treatment with SnCl2 (10 lmol/L, 24 hours) led
to increased HO-1 protein levels by 2.9-fold and 1.8-fold
in endothelial and vascular smooth muscle cells, respec-
tively; however, no apparent change in HO-1 protein ex-
pression was found in TALH cells after the same exposure
to SnCl2. The addition of heme (10 lmol/L, 24 hours)
caused 4.3-fold and 4.1-fold increases in HO-1 protein
levels in endothelial cells and vascular smooth muscle
cells, respectively, whereas only a modest increase (30%)
in HO-1 protein was detected in TALH cells. None of
these treatments affected the levels of HO-2 protein (data
not shown). These data indicate that the responsiveness
of TALH cells to HO-1 inducers is significantly reduced
compared to that of endothelial cells or vascular smooth
muscle cells.
Effect of heme and Ang II on COX-2 and HO-1
protein expression
Since heme and Ang II stimulate COX-2 protein ex-
pression and enhance PGE2 synthesis in endothelial cells
[30, 31], we determined whether these agents could ac-
tivate COX-2 protein in TALH primary cell cultures.
Figure 2A shows that exposure to Ang II (100 ng/mL)
and heme (10 lmol/L) for 24 hours resulted in a signif-
icant increase in COX-2 protein expression by 41% and
27%, respectively. Again, exposure to heme and Ang II
resulted in a modest increase in HO-1 protein in TALH
primary cell cultures (Fig. 2B).
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Fig. 1. Western blot analyses in thick ascending loop of Henle (TALH)
(A), endothelial (EC) (B), and vascular smooth muscle cells (VSMC)
(C). Cells were treated with SnCl2 (10 lmol/L) or heme (10 lmol/L)
for 24 hours. Control rat heme oxygenase-1 (HO-1) protein expression
(relative optical density) was arbitrarily set to 1 and compared with cells
treated with SnCl2 or heme. The plot shown is representative of three
different experiments. Con is control.
Functional expression of human HO-1 in TALH
transduced with ADNKCC2-HO-1
To study the site-specific HO-1 expression in TALH,
we examined the ability of the adenovirus, Ad-NKCC2-
HO-1, to express HO-1 protein in other cell types, such
as endothelial cells, as well as in TALH. After 48 hours
of infection with Ad-NKCC2-HO-1 and the control ade-
novirus Ad-lacZ, the cells were subjected to RT-PCR.
Western blot analysis and HO activity assay were used
to assess the functional expression of human HO-1 in
TALH. RT-PCR analyses showed that human HO-1 tran-
scripts were detected in TALH cells infected with Ad-
NKCC2-HO-1, but were not detected in control TALH
cells or in TALH cells infected with Ad-lacZ (Fig. 3A).
Cell-specific expression was further examined in an en-
dothelial cell line.
Ad-NKCC2-HO-1 caused pronounced expression of
human HO-1 protein in mTAL cells (Fig. 3B), but not in
rat microvessel endothelial cells (Fig. 3C). There was no
HO-1 signal detected in mTAL after infection with the
control empty viral vector or virus Ad-lacZ. Moreover,
rat HO-2 protein expression was not affected in TALH
cells injected by either adenovirus.
HO activity was assayed in both TALH and endothelial
cells after exposure to either Ad-NKCC2-HO-1 or con-
trol adenovirus, Ad-lacZ, for two days (Fig. 4A). HO ac-
tivity in TALH cells infected with Ad-NKCC2-HO-1 was
significantly (1.81-fold) higher than that in TALH cells
infected with Ad-lacZ (P < 0.05). However, there was no
significant difference in HO activity between endothelial
cells infected with Ad-NKCC2-HO-1 and Ad-lacZ, in-
dicating that the Ad-NKCC2-HO-1 increases HO-1 ex-
pression specifically in TALH cells, but not in endothelial
cells.
Transduced human HO-1 and endogenous rat HO-2
expression were measured in cultured TALH and en-
dothelial cells after infection with adenoviruses for 2 days
using FITC (for human HO-1) or Cy3 (for HO-2)-labeled
antibodies and viewed by confocal microscopy as seen
in Figure 4B. Human HO-1 expression was detected in
TALH cells infected with adenovirus Ad-NKCC2P-HO-
1 (Fig. 4A and C), but not in TALH cells infected with
Ad-lacZ (data not shown). Moreover, human HO-1 was
not detected in endothelial cells infected with either Ad-
NKCC2-HO-1 or Ad-lacZ (data not shown).
Effect of Ad-NKCC2-HO-1 transduction on PGE2
production in TALH cells
Since infection of TALH cells with Ad-NKCC2-HO-1
significantly increased human HO-1 protein expression
and total HO activity, we next examined whether over-
expression of HO-1 via this route could affect the produc-
tion of COX-2 activity, as measured by PGE2, released in
cultured media. As seen in Figure 5, infection of TALH
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Fig. 2. Western blot analysis of cyclooxygenase-2 (COX-2) (A) and rat
heme oxygenase (HO-1) (B) protein expression in thick ascending loop
of Henle (TALH) cells. Cells were exposed to heme (10 lmol/L) or an-
giotensin II (Ang II) (100 ng/mL) for 24 hours. Relative optical densities
of HO-1 or COX-2 protein expression in control (con) untreated TALH
cells were set to 1 and were compared with those in cells treated with
heme and Ang II and shown under each panel (N = 3, ∗P < 0.05 vs.
control).
cells with Ad-NKCC2-HO-1 (50 MOI for 2 days) alone
did not cause a significant change in PGE2 production
(519 ± 41 pg/mL) compared with control TALH cells
(468 ± 20 pg/mL) infected with control adenovirus Ad-
lacZ. The addition of heme (10 lmol/L) for 24 hours
to TALH infected with Ad-NKCC2-HO-1 or control
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Fig. 3. Analyses of human heme oxygenase (HO), rat b-actin mRNA
in thick ascending loop of Henle (TALH) and microvessel endothelial
cells (EC). (A) Reverse transcription-polymerase chain reaction (RT-
PCR) analysis of human HO-1 and rat b-actin mRNA in TALH cells
infected with adenoviruses for 2 days. The specific primers for human
HO-1 and rat b-actin are described in Table 1. (B) Western blot analysis
of human HO-1 and rat HO-2 in TALH and microvessel EC (C) infected
with adenovirus Ad-NKCC2-HO-1, Ad-CMV-HO-1 (positive control)
or Ad-lacZ (negative control). Cells were infected with adenoviruses
for 2 days.
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HO-2 expressions were viewed by confocal microscopy. Human HO-
1 (panels a and c) and rat HO-2 (panels b and d) immunoreactivity
is shown in Ad-NKCC2-HO-1–infected TALH cells using fluorescein
isothiocyanate (FITC)-conjugated antihuman HO-1 and Cy-3 conju-
gated anti-HO-2, respectively [original magnifications 100× (a and b)
and 400× (c and d).
adenovirus resulted in a significant increase of PGE2
compared to control TALH cells (P < 0.05). There was
no significant difference in PGE2 production between
mTAL cells infected with either Ad-NKCC2-HO-1 or
Ad-lacZ after exposure to heme (P > 0.05). However,
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Fig. 5. Prostaglandin E2 (PGE2) production in thick ascending loop
of Henle (TALH) cells. Cells were infected with Ad-NKCC2-HO-1
(50 MOI) or Ad-lacZ (50 MOI) 24 hours before being treated with heme
(10 lmol/L) or angiotensin II (Ang II) (100 ng/mL) and incubated for
an additional 24 hours. Cultured media were used for measurement of
PGE2 production by enzyme-linked immunosorbent assay (ELISA)
[∗P < 0.05 vs. corresponding control virus-infected TALH cells;
#P < 0.05 vs. Ad-lacZ-infected medullary thick ascending loop (mTAL)
cells].
Table 2. Angiotensin II (Ang II)–mediated cellular free heme
content changes in thick ascending loop of Henle (TALH) cells
pre-infected with adenoviruses, Ad-NKCC2-HO-1 or Ad-lacZ
Heme content pmol/mg
Treatment microsomal protein
Ad-lacZ 411.7 ± 75.8
Ad-lacZ + Ang II 389.7 ± 20.6
Ad-NKCC2-HO-1 293.0 ± 43.3∗
Ad-NKCC2-HO-1 + Ang II 305.3 ± 21.2∗
Fifty percent confluent TALH cells were infected with adenoviruses, Ad-
NKCC2-HO-1 (50 MOI) or Ad-lacZ (50 MOI), for 24 hours before treatment
with Ang II (100 ng/mL) for an additional 24 hours. Cellular-free heme content
was measured as described in the Methods section (N = 3, P < 0.05 vs. corre-
sponding control cells).
in TALH cells infected with Ad-NKCC2-HO-1, Ang II–
stimulated production of PGE2 was greatly attenuated.
Effect of targeting TALH cells with human HO-1
on endogenous cellular heme
To investigate the effects of targeting TALH with HO-
1 gene on cellular heme, a pro-oxidant, cells were infected
with the Ad-NKCC2-HO-1 or Ad-lacZ, and 2 days later
microsomal heme levels were measured. As shown in
Table 2, in TALH cells infected with Ad-NKCC2-HO-1,
cellular free-heme content was decreased to 293.0 ± 43.3
pmol/mg compared to 411.7 ± 75.8 pmol/mg in TALH
cells infected with control adenovirus Ad-lacZ (P < 0.05).
Cellular heme levels in Ad-lacZ or Ad-NKCC2-HO-1–
infected cells were not altered in response to Ang II
(Table 2).
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Fig. 6. Effect of human heme oxygenase-1
(HO-1) gene transfer on angiotensin II (Ang
II)–induced DNA damage. Thick ascending
loop of Henle (TALH) cells were stimulated
for 16 hours by Ang II (200 ng/mL) alone
or in cells infected with Ad-NKCC2-HO-1
or Ad-lacZ (50 MOI, 2 days) and then sub-
jected to Ang II. The histograms demonstrate
DNA damage, as measured by COMET as-
say and expressed as mean of tail moment
(TMOM). Treatment is representative of an
average mean of TMOM ± SE of three in-
dividual slide determinations. On each slide,
50 COMETs were scored blindly for TMOM.
Significantly different values (∗P < 0.05 vs.
control; #P < 0.05 vs. Ang II alone) were de-
termined by analysis of variance (ANOVA)
multiple range testing.
Control Ang II Ad-NKCC2P-
HO-1  +  Ang II
Fig. 7. Morphologic determination of
COMET in cells treated with angiotensin II
(Ang II). Representative microphotographs
of agarose low melting minigel thick ascend-
ing loop of Henle (TALH) cells treated with
vehicle control (A), Ang II (200 ng/mL)
for 16 hours (B), or Ad-NKCC2P-HO-1
(50 MOI) for 2 days, then Ang II (200
ng/mL) for 16 hours (C). Damaged DNA
migrates during electrophoresis from the
nucleus toward the anode, forming a shape
of a “comet” with a head (cell nucleus with
intact DNA) and a tail (relaxed and broken
DNA). Images were taken by a fluorescence
microscope (rodamine filter) plugged with a
digital camera after staining with ethedium
bromide (original magnification 40×).
Effect of human HO-1 gene on Ang II–mediated
genotoxic damage
Since Ang II and oxidant-inducing agents have been
shown to cause apoptosis in several renal cell types, in-
cluding TALH [32–35], we reasoned that cell-specific
expression of HO-1 in TALH may attenuate Ang II–
mediated DNA damage. To test this hypothesis, serum-
starved TALH cells were exposed to Ang II for 16 hours
and DNA integrity was analyzed by COMET assay as
shown in Figure 6. Ang II increased TMOM levels from
54 ± 9 in the control cells to 143 ± 12. In contrast, in cells
transfected with human HO-1 Ang II–mediated DNA
damage was greatly diminished, suggesting that HO-1
does shield the cells from the initial genotoxic effect pro-
duced by Ang II. TMOM levels in cells incubated with
bilirubin were not significantly different from the control
cells. The addition of bilirubin to Ang II–exposed cells
attenuated DNA damage, suggesting that HO-1–derived
bilirubin, from NKCC2 HO-1 expression, decreases Ang
II–mediated oxidative injury.
Morphologic measurements of COMET in cells
treated with Ang II
We measured the morphologic changes in cells treated
with Ang II and assessed the effect of inducers on
COMET changes. No DNA damage was detected in con-
trol, nontreated cells. In fact, the DNA remains intact
as shown in Figure 7. Following treatment with Ang II
(200 ng/mL for 16 hours), which induced DNA single-
strand breaks, distinct COMETs were observed. The ex-
tent of DNA damage was quantitated by image analysis
to produce a tail moment, defined as the product of the
percentage of DNA in the COMET tail and the distance
between the means of the head and tail distributions [36].
As seen in Figure 7, COMET appearance is clearly seen
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Fig. 8. Determination of reduced growth-stimulating hormone (GSH)
content. GSH levels were measured in control thick ascending loop of
Henle (TALH) cells (A) and TALH cells infected with Ad-NKCC2P-
HO-1 or Ad-lacZ (B) treated with and without angiotensin II (Ang
II) or bilirubin. GSH levels were measured spectrophotometrically and
expressed as mean ± SE (nmol/mg of protein) of three individual exper-
iments. Significantly different values (∗P < 0.05 vs. control; ∗∗P < 0.05 vs.
control + Ang II) were determined by analysis of variance (ANOVA)
multiple range testing.
at higher levels in Ang II compared to control cells. Cells
pretreated with Ang II and Ad-NKCC2 HO-1 showed a
similar profile to the nontreated cells. Pretreatment with
Ad-lacZ control virus failed to maintain DNA integrity
in presence of Ang II, suggesting that HO-1 expression
was instrumental in attenuating the Ang II–mediated in-
crease in COMETs.
Effect of Ang II on GSH
Previous studies have provided evidence that Ang II–
mediated reactive oxygen species (ROS) can have a ma-
jor effect on the redox status of localized pools of GSH
[37], which affects the level of oxygen in TALH. We mea-
sured the effect of bilirubin, a product of HO activity
with antioxidant properties, on GSH levels. As seen in
Figure 8, the addition of bilirubin increased the levels of
endogenous GSH in cultured mTAL cells after 24 hours
of exposure. In contrast, incubation of mTAL cells with
Ang II decreased the levels of GSH, which was reversed
by supplementation of bilirubin. Similar results were ob-
served when TALH were infected with Ad-NKCC2-HO-
1 for 2 days. A significant increase in GSH levels was
observed compared to control (P < 0.001). Although
Ad-NKCC2-HO-1 reversed the effect of the Ang II–
mediated decrease in GSH, Ad-NKCC2-HO-1 enhances
the levels of GSH significantly greater than that which
occurs with bilirubin.
DISCUSSION
The balance between the action of oxidative stress com-
pounds and the physiologic defense against them appears
to be a determining factor in the pathogenesis of diverse
renal diseases, including ischemic/reperfusion injury. Ang
II, heme, and other inflammatory molecules may shift this
balance in favor of free radical–mediated epithelial cell
injury [33, 38–41]. Induction of HO-1 gene expression
has been suggested to be an adaptive response to ox-
idative stress injury [42, 43]. Hemoglobin and myoglobin
are potential sources of free radical oxidants and renal
inflammation [44–46]. Furthermore, heme moieties re-
leased from heme proteins have been shown to promote
the formation of free oxygen radicals and DNA degrada-
tion [9]. Pertinent to the role of HO in renal injury is the
study of Nath et al [44]. These investigators demonstrated
that in vivo induction of HO prevents renal failure and
drastically reduces mortality after glycerol-induced rhab-
domyolysis in the rat; a condition that is characterized
by an increased release of myoglobin and hemoglobin,
resulting in irreversible renal tissue injury, renal failure
and death. Oxidative-mediated tissue damage is also as-
sociated with up-regulation of monocyte chemoattractant
protein-1 (MCP-1), a major factor in the development of
renal disease [47].
The TALH, as the renal region most susceptible to ox-
idant injury, is a practical target for antioxidant therapy
such as that provided by HO-1 overexpression. Previous
studies in our laboratory indicated that HO-1 expression
is very low in freshly isolated TALH and can be greatly
induced with chemical inducers of HO-1 [21]. In con-
trast, primary cultures of TALH in this study showed a
significant level of HO-1 expression. It is possible that, in
vivo, HO-1 is controlled by suppressor factors including
glucocorticoids [48, 49], interferon gamma (INF-c) [50],
Bach-1 transcriptional factors [51], and hypoxia [52]. On
the other hand, placing cells in culture in a medium con-
taining serum may up-regulate HO-1 expression. Nev-
ertheless, we were able to successfully enhance HO-1
expression by transduction of human HO-1 gene into
rat TALH using the cell specific promoter, NKCC2. The
transduced HO-1 gene induced the expression of human
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HO-1 gene without affecting expression of endogenous
rat HO-1 or altering the rat HO-2 gene. Infection of en-
dothelial cells or vascular smooth muscle cells with the
TALH specific adenovirus, Ad-NKCC2-HO-1, did not
result in functional HO-1 expression or HO activity. Se-
lective delivery of the human HO-1 gene to TALH, using
the NKCC2 promoter, increased HO activity leading to
decreased heme levels and increased production of biliru-
bin and CO. The increased in the levels of bilirubin and
CO, which exhibit antioxidant and antiapoptotic proper-
ties, may contribute to the cytoprotective action of HO-1
overexpression against oxidant injury brought about by
Ang II (vide infra).
We have previously showed that endothelial cells sta-
bly transfected with the human HO-1 gene exhibited
a several-fold increase in human HO-1 mRNA levels,
which was accompanied by an increase in HO activity
and a marked decrease in PGE2 associated with selec-
tive down-regulation of COX-2 but not COX-1 [30]. We
also demonstrated that the degree of HO-1 expression is
inversely related to COX activity and that this is linked
to the levels of cellular heme [30]. Hence, addition of
heme to cells overexpressing HO-1 resulted in an in-
crease in COX activity [30]. More recently, others have
confirmed the finding that HO-1 overexpression down-
regulates COX-2 activity due to the availability of heme,
an essential cofactor for COX activity [53]. Unlike en-
dothelial cells, TALH cells overexpressing HO-1 showed
no change in PGE2 levels. However, while Ang II induced
COX-2 expression in TALH, overexpression of HO-1
greatly attenuated Ang II–induced PGE2 production.
The mechanism of this effect is unclear. It is possible that
HO-1 overexpression inhibits Ang II action by affecting
Ang II–induced mechanisms upstream of COX-2 (e.g.,
production of ROS). The ability of HO-1 overexpres-
sion to inhibit Ang II–stimulated PGE2 may represent
additional means by which it provides cytoprotection. To
this end, studies have shown that Ang II induces TNF
production by the TALH and that this effect is COX-2–
dependent [21].
Another important key finding, crucial for TALH sur-
vival, is that selective delivery of the human HO-1 gene
attenuated Ang II–mediated genotoxic damage, stem-
ming from the generation of O2 and the formation of hy-
droxyl radicals [54]. The increase in HO-1 activity and the
subsequent generation of bilirubin, an antioxidant and
hydroxyl radical scavenger, prevented DNA degradation
and increased antioxidant mechanisms such as GSH lev-
els in TALH. Bilirubin and biliverdin both act as antiox-
idants in vitro and in vivo [10] and their increased local
concentrations, after HO induction, are beneficial in pro-
tecting endothelial cells from injury [9].
Studies from this laboratory and others have demon-
strated that HO-1 gene overexpression provides a cyto-
protective effect against the inflammatory response to
TNF and Ang II, preserves DNA integrity, and main-
tains normal cell cycle progression [7, 8, 13]. We, as well
as others, have shown that HO-1 overexpression attenu-
ates cell death by oxidants such as H2O2 and TNF [16,
55], an affect attributed to CO. CO has been shown to
play an important role in controlling cell cycle progres-
sion [7, 14, 16], signifying the important role of this gas in
cell growth. Others have shown that when an inhibitor of
HO blocks HO activity or the action of CO is inhibited,
endothelial cell apoptosis no longer prevented [13]. How-
ever, the effect of CO has been shown to be cell specific;
in endothelial cells, CO enhances cell growth, whereas,
CO inhibits vascular smooth muscle cell growth [56–61].
It has been shown, that in the one kidney, one clip
(1K1C) mouse model, HO-1 deficiency exacerbated hy-
pertension and induced acute ischemic renal failure [62].
HO-1 has been shown to be up-regulated in the kidney
of Ang II–induced hypertensive rats [63]. In rats trans-
duced with human HO-1, Ang II pressor responsiveness
is greatly attenuated [abstract; Yang L, et al, Hyperten-
sion 42:P11-P407, 2003] [64]. Ang II–receptor blockade
with losartan has been shown to prevent oxidative stress-
induced hypertension in rats [65]. Renal tubular injury, as
a major pathologic feature, has been described in human
HO-1 deficiency [66]. Induction of HO-1 has been shown
to protect against cisplatin nephrotoxicity in the rat [46].
Our study demonstrates that the up-regulation of HO-
1 in the TALH provides protection against Ang II–
mediated DNA degradation caused by oxidative injury.
It supports the notion that the induction of HO-1 and
formation of bilirubin and CO are central features of
this antioxidative mechanism in TALH. This may play
an important role in preventing renal damage produced
by tubular hypoxic and oxidative damage with resulting
inflammation and apoptosis.
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